Projected rebound of PH pharma at risk — PHAP

The domestic pharmaceutical and healthcare industry has been forecasted to rebound this year with a 5-6 percent growth from a negative 11 percent in 2020, but initial results are not actually looking good, according to a top industry leader. Dr. Beaver Tamesis, president of the Pharmaceutical and Healthcare Association of … Continue reading Projected rebound of PH pharma at risk — PHAP